CN108578277A - A kind of cosmetics with anti-aging, whitening, moisture-keeping efficacy - Google Patents
A kind of cosmetics with anti-aging, whitening, moisture-keeping efficacy Download PDFInfo
- Publication number
- CN108578277A CN108578277A CN201810543087.5A CN201810543087A CN108578277A CN 108578277 A CN108578277 A CN 108578277A CN 201810543087 A CN201810543087 A CN 201810543087A CN 108578277 A CN108578277 A CN 108578277A
- Authority
- CN
- China
- Prior art keywords
- arg
- pro
- trp
- ser
- ambystoma
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Pending
Links
Classifications
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K8/00—Cosmetics or similar toiletry preparations
- A61K8/18—Cosmetics or similar toiletry preparations characterised by the composition
- A61K8/30—Cosmetics or similar toiletry preparations characterised by the composition containing organic compounds
- A61K8/64—Proteins; Peptides; Derivatives or degradation products thereof
- A61K8/645—Proteins of vegetable origin; Derivatives or degradation products thereof
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K8/00—Cosmetics or similar toiletry preparations
- A61K8/18—Cosmetics or similar toiletry preparations characterised by the composition
- A61K8/30—Cosmetics or similar toiletry preparations characterised by the composition containing organic compounds
- A61K8/33—Cosmetics or similar toiletry preparations characterised by the composition containing organic compounds containing oxygen
- A61K8/34—Alcohols
- A61K8/345—Alcohols containing more than one hydroxy group
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K8/00—Cosmetics or similar toiletry preparations
- A61K8/18—Cosmetics or similar toiletry preparations characterised by the composition
- A61K8/30—Cosmetics or similar toiletry preparations characterised by the composition containing organic compounds
- A61K8/33—Cosmetics or similar toiletry preparations characterised by the composition containing organic compounds containing oxygen
- A61K8/36—Carboxylic acids; Salts or anhydrides thereof
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K8/00—Cosmetics or similar toiletry preparations
- A61K8/18—Cosmetics or similar toiletry preparations characterised by the composition
- A61K8/30—Cosmetics or similar toiletry preparations characterised by the composition containing organic compounds
- A61K8/33—Cosmetics or similar toiletry preparations characterised by the composition containing organic compounds containing oxygen
- A61K8/36—Carboxylic acids; Salts or anhydrides thereof
- A61K8/365—Hydroxycarboxylic acids; Ketocarboxylic acids
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K8/00—Cosmetics or similar toiletry preparations
- A61K8/18—Cosmetics or similar toiletry preparations characterised by the composition
- A61K8/30—Cosmetics or similar toiletry preparations characterised by the composition containing organic compounds
- A61K8/40—Cosmetics or similar toiletry preparations characterised by the composition containing organic compounds containing nitrogen
- A61K8/42—Amides
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K8/00—Cosmetics or similar toiletry preparations
- A61K8/18—Cosmetics or similar toiletry preparations characterised by the composition
- A61K8/30—Cosmetics or similar toiletry preparations characterised by the composition containing organic compounds
- A61K8/49—Cosmetics or similar toiletry preparations characterised by the composition containing organic compounds containing heterocyclic compounds
- A61K8/4906—Cosmetics or similar toiletry preparations characterised by the composition containing organic compounds containing heterocyclic compounds with one nitrogen as the only hetero atom
- A61K8/4913—Cosmetics or similar toiletry preparations characterised by the composition containing organic compounds containing heterocyclic compounds with one nitrogen as the only hetero atom having five membered rings, e.g. pyrrolidone carboxylic acid
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K8/00—Cosmetics or similar toiletry preparations
- A61K8/18—Cosmetics or similar toiletry preparations characterised by the composition
- A61K8/30—Cosmetics or similar toiletry preparations characterised by the composition containing organic compounds
- A61K8/64—Proteins; Peptides; Derivatives or degradation products thereof
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K8/00—Cosmetics or similar toiletry preparations
- A61K8/18—Cosmetics or similar toiletry preparations characterised by the composition
- A61K8/30—Cosmetics or similar toiletry preparations characterised by the composition containing organic compounds
- A61K8/67—Vitamins
- A61K8/678—Tocopherol, i.e. vitamin E
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K8/00—Cosmetics or similar toiletry preparations
- A61K8/18—Cosmetics or similar toiletry preparations characterised by the composition
- A61K8/92—Oils, fats or waxes; Derivatives thereof, e.g. hydrogenation products thereof
- A61K8/922—Oils, fats or waxes; Derivatives thereof, e.g. hydrogenation products thereof of vegetable origin
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61Q—SPECIFIC USE OF COSMETICS OR SIMILAR TOILETRY PREPARATIONS
- A61Q19/00—Preparations for care of the skin
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61Q—SPECIFIC USE OF COSMETICS OR SIMILAR TOILETRY PREPARATIONS
- A61Q19/00—Preparations for care of the skin
- A61Q19/02—Preparations for care of the skin for chemically bleaching or whitening the skin
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61Q—SPECIFIC USE OF COSMETICS OR SIMILAR TOILETRY PREPARATIONS
- A61Q19/00—Preparations for care of the skin
- A61Q19/08—Anti-ageing preparations
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07K—PEPTIDES
- C07K7/00—Peptides having 5 to 20 amino acids in a fully defined sequence; Derivatives thereof
- C07K7/04—Linear peptides containing only normal peptide links
- C07K7/08—Linear peptides containing only normal peptide links having 12 to 20 amino acids
-
- C—CHEMISTRY; METALLURGY
- C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
- C12P—FERMENTATION OR ENZYME-USING PROCESSES TO SYNTHESISE A DESIRED CHEMICAL COMPOUND OR COMPOSITION OR TO SEPARATE OPTICAL ISOMERS FROM A RACEMIC MIXTURE
- C12P21/00—Preparation of peptides or proteins
- C12P21/06—Preparation of peptides or proteins produced by the hydrolysis of a peptide bond, e.g. hydrolysate products
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K2800/00—Properties of cosmetic compositions or active ingredients thereof or formulation aids used therein and process related aspects
- A61K2800/40—Chemical, physico-chemical or functional or structural properties of particular ingredients
- A61K2800/59—Mixtures
- A61K2800/592—Mixtures of compounds complementing their respective functions
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K2800/00—Properties of cosmetic compositions or active ingredients thereof or formulation aids used therein and process related aspects
- A61K2800/70—Biological properties of the composition as a whole
- A61K2800/72—Hypo-allergenic
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K2800/00—Properties of cosmetic compositions or active ingredients thereof or formulation aids used therein and process related aspects
- A61K2800/80—Process related aspects concerning the preparation of the cosmetic composition or the storage or application thereof
- A61K2800/83—Electrophoresis; Electrodes; Electrolytic phenomena
Landscapes
- Health & Medical Sciences (AREA)
- Life Sciences & Earth Sciences (AREA)
- General Health & Medical Sciences (AREA)
- Animal Behavior & Ethology (AREA)
- Public Health (AREA)
- Veterinary Medicine (AREA)
- Birds (AREA)
- Epidemiology (AREA)
- Chemical & Material Sciences (AREA)
- Organic Chemistry (AREA)
- Emergency Medicine (AREA)
- Dermatology (AREA)
- Engineering & Computer Science (AREA)
- Genetics & Genomics (AREA)
- Molecular Biology (AREA)
- Biochemistry (AREA)
- Zoology (AREA)
- Wood Science & Technology (AREA)
- General Engineering & Computer Science (AREA)
- Oil, Petroleum & Natural Gas (AREA)
- General Chemical & Material Sciences (AREA)
- Chemical Kinetics & Catalysis (AREA)
- Biotechnology (AREA)
- Bioinformatics & Cheminformatics (AREA)
- Microbiology (AREA)
- Gerontology & Geriatric Medicine (AREA)
- Biophysics (AREA)
- Medicinal Chemistry (AREA)
- Proteomics, Peptides & Aminoacids (AREA)
- Cosmetics (AREA)
- Peptides Or Proteins (AREA)
Abstract
The invention discloses it is a kind of with anti-aging, whitening, moisture-keeping efficacy cosmetics, by 0.1 part of pomegranate polypeptide, 2 parts of olive oil, 0.5 part of D panthenols, 0.5 part of vitamin E, 0.1 part of glutathione, 1 part of pyrrolidone sodium carboxylate, 2 parts of glycerine, 1 part of sodium lactate, 0.1 part of essence, 5 parts of purified water compositions.The cosmetic material of the present invention is cheap, abundance, natural, mild, non-stimulated to skin, and various active substance acts synergistically on skin, and effect is better than ordinary cosmetics.
Description
Technical field
The present invention relates to a kind of cosmetics, for the anti-aging of skin, whitening, moisturizing.
Background technology
Skin is to be covered in human body surface ー vitals, by the appendicle of epidermis, corium, subcutaneous tissue and skin
Official is constituted.Skin is the natural cover for defense together between external environment and body, protects the organ in body from temperature and humidity
The influence of variation and the influence of external environment (such as ultraviolet light and pollutant), however, the protective effect of skin is limited
, when external influence is more than certain degree, skin aging is inevitable with regard to Cheng Wei ー kinds.
Anti-aging cosmetics have accounted for 50% of Cosmetic Market or more.One of main factor of skin aging is skin
Skin photosensitiveness aging caused by by ultraviolet radioactive for a long time.The light aging of skin is since free-radical contents increase in skin, freely
Base can damage biological film, promote elastomer to crosslink and polymerize, accelerate the aging of skin.Confrontation and elimination free radical prevent
The damaging action of free radical, is realized often through antioxidant.Current antioxidant is divided into two classes:First, non-enzyme is anti-oxidant
Agent, such as VE, VC;Another kind of is enzyme antioxidant, wherein most popular is superoxide dismutase.This two classes antioxygen
After agent is added in cosmetics, stability of the enzyme antioxidant in cosmetics is poor, and since molecular weight is larger, penetrates into
Skin is restricted, therefore its use still has limitation.Therefore, more good using small molecule non-enzyme antioxidant.And
Vitamin series non-enzyme antioxidant also limits its application in cosmetics since stability is poor.Grinding in recent years
Study carefully discovery, the Molecular antioxidant substances extracted from plant, Chinese herbal medicine etc. such as polypeptide is Wheat Protein a bit, still
Its effect is not also apparent.
Pomegranate is Punicaceae (Punicaceae), Punica, machaka or dungarunga.Pomegranate is full of nutrition, sugar content
Up toTartaric acidMoisture content 79%, protein, fat respectively account for 0.6%, and ascorbic content is apple
With pearsTimes, it is especially the most prominent with the content of phosphorus, per hectogram up to 145 milligrams, come out at the top in fruit.Juice of my pomegranate is red
Element has certain Scavenging activity to DPPH, and antioxidation is close with Vc, and the juice of my pomegranate haematochrome of 2.Omg/ml is to the clear of DPPH
Except rate is up to 91.48%, show that juice of my pomegranate haematochrome has good antioxidant activity.Juice of my pomegranate haematochrome is added to cosmetics and matches
Fang Zhong has found after tested:The cosmetics after using 28 days, dispel obviously by epidermis smooth cut, and the tight system of skin is promoted, and is slowed down aging
The effect of it is apparent.But the cosmetics exploitation at present based on pomegranate is not yet ripe, does not there is relevant utilization.With very big
Application prospect.
Invention content
Polypeptide is extracted as the anti-aging cosmetics of main active using pomegranate the object of the present invention is to provide a kind of, is utilized
The pomegranate polypeptide extracted is added in cosmetic formulations, is equipped with other auxiliary materials and cosmetics that component is prepared.By surveying
Trying the cosmetics has good anti-aging function.
The anti-aging cosmetics of this invention Ti Chu ー kind external applications, which is characterized in that be made of each component of following parts by weight:
0.1 part of pomegranate polypeptide, 2 parts of olive oil, 0.5 part of D-pantothenyl aleohol, 0.5 part of vitamin E, 0.1 part of glutathione, 2-pyrrolidone-5-carboxylic acid
1 part of sodium, 2 parts of glycerine, 1 part of sodium lactate, 0.1 part of essence, 5 parts of purified waters.
The present invention additionally provides a kind of preparation methods of pomegranate polypeptide, and (1) cleans up pomegranate, rub, squeeze the juice, and are added
Papain and trypsase, enzyme concentration 20000IU/g pomegranates, 55 DEG C of hydrolysis temperature, pH value 7.0, enzymolysis time 3h, enzymolysis
92 DEG C of enzyme deactivation 13min after the completion;
(2) material filtering after enzyme deactivation removes insoluble matter, obtains solution, and 4% activated carbon adsorption is added in gained polypeptide solution
Decoloration carries out peptide separation, the elution of 20mmol/L HCl solutions, flow velocity 1.3mL/ with glucan G-50 (Sephadex G-50)
Minute, eluted product in different time periods is collected respectively, adjusts solution to pH7.0,10000 revs/min centrifuge 15 minutes, through big
It after the resin DA201-C desalting processings of hole, is concentrated in vacuo, supernatant freeze-drying is spare;Through sodium dodecyl sulfate-polypropylene acyl
Amine gel electrophoresis (SDS-PAGE), recycles the band of small-molecular-weight, wherein passing through functional verification, the sequence of 60 small peptides is obtained
Has the function of anti-aging.According to the peak separation time different in chromatographic column, corresponding small peptide can be obtained in batches, it also can people
The work synthesis polypeptide.The sequence of the polypeptide such as SEQ ID NO:Shown in 1-60.
The beneficial effects of the invention are as follows:
The cosmetic material of the present invention is cheap, abundance.Pomegranate polypeptide is combined with other active materials, can be more preferable
Nourishes rough skin, effectively prevent and to anti-wrinkle generate, increase skin elasticity, slow down aging.The present invention use pomegranate polypeptide for
The cosmetics that raw material is prepared, it is natural, mild, non-stimulated to skin, and also various active substance acts synergistically on skin,
Effect is better than ordinary cosmetics.
The detailed description of preferred embodiment
Following example illustrate each aspect of the present invention contents.They are only to illustrate, and do not limit the model of the present invention
It encloses.
The preparation of 1 polypeptide of embodiment
(I) pomegranate is cleaned up, rubs, squeezes the juice, papain and trypsase, enzyme concentration 20000IU/g is added
Pomegranate, 55 DEG C of hydrolysis temperature, pH value 7.0, enzymolysis time 3h, 92 DEG C of enzyme deactivation 13min after the completion of enzymolysis;
(2) material filtering after enzyme deactivation removes insoluble matter, obtains solution, and 4% activated carbon adsorption is added in gained polypeptide solution
Decoloration carries out peptide separation, the elution of 20mmol/L HCl solutions, flow velocity 1.3mL/ with glucan G-50 (Sephadex G-50)
Minute, eluted product in different time periods is collected respectively, adjusts solution to pH7.0,10000 revs/min centrifuge 15 minutes, through big
It after the resin DA201-C desalting processings of hole, is concentrated in vacuo, supernatant freeze-drying is spare;Through sodium dodecyl sulfate-polypropylene acyl
Amine gel electrophoresis (SDS-PAGE), recycles the band of small-molecular-weight, wherein passing through functional verification, the sequence of 60 small peptides is obtained
Has the function of anti-aging.The sequence of the polypeptide such as SEQ ID NO:Shown in 1-60, corresponding entitled HFP-1~
HFP-60。
The preparation of 2 cosmetics of embodiment
HFP-10.1 parts of pomegranate polypeptide is taken respectively, is dissolved with 2 parts of 2 parts of glycerine and olive oil.Add successively under stiring
Enter 0.5 part of D-pantothenyl aleohol, 0.5 part of vitamin E, 0.1 part of glutathione, 1 part of pyrrolidone sodium carboxylate, 1 part of sodium lactate, essence 0.1
Part, being sufficiently stirred makes to be completely dissolved, mixing, adjust the pH of solution toFormula total amount finally is supplied with 5 parts of purified waters,
Aseptic filtration, packing, as finished product cosmetics.
The preparation of 3 cosmetics HFP-2~60 of embodiment
According to the method for embodiment 2, pomegranate polypeptide is replaced with into HFP-2~60 totally 59 kinds of forms respectively, remaining component and
Preparation method and embodiment 2 are identical, and the cosmetics are prepared.
Embodiment 4 compares the preparation of cosmetics
According to the method for embodiment 2, wherein being added without corresponding pomegranate polypeptide, remaining component and method and 2 phase of embodiment
Together, corresponding cosmetics are prepared.
5 security verification of embodiment
Test material and method
Animal:Regular grade experimental animal White Rabbit.Body looks into animal no abnormality seen.
Environmental condition:Room temperature:22 DEG C -23 DEG C, relative humidity:66% -68%;
Test method:
Foundation《Cosmetics health specification》(version in 2007) acute skin irritation is tested, and is tested first 24 hours, will be tested
Back part of animal backbone diamond wool is cut, 3 centimetres of unhairing range, 3 centimetres of X.0.5 gram of tested no originality is taken directly to be applied to right side skin
On skin, covered with clean gauze, with nonirritant immobilization with adhesive tape 2 hours.Other side is negative control.After removing tested material
It observes animal subject contact site dermoreaction and keeps a record within 1 hour, 24 hours, 72 hours 48 hours.
Conclusion:
Under this experimental condition, tested material contains the cosmetics of pomegranate polypeptide to White Rabbit acute skin irritation test by skin
Skin stimulus intensity is classified as nonirritant.It is also nonirritant to compare cosmetics.
6 cosmetics moisturizing degree of embodiment and moisture preserving time detection
MMV (moisturemeasurementvalue) method detects the ability of MMV values reflection keratoderma combination water.It adopts
The aquation of skin is tested with CM825 type skin oil-water soda acid testers.Its measuring principle is since cuticula contains greatly
The electrolyte of amount, the electrolyte deposited in water is conductive, and this phenomenon is also generated in skin surface, by test probe with
After skin contact, conductivity changes to reflect the hydration status of skin.
Subject is health without dermopathic volunteer.The temperature and humidity of environment is constant during experimental condition is test,
Temperature is 25 DEG C ± 2 DEG C, and relative humidity is 40%~60%.
Health is chosen without dermopathic volunteer 62, is tested.Test method is:1. determining the 4 pieces of surveys of left and right forearm
Region is tried, region area 4cmX4cm tests the blank value in the region respectively.2. sample is coated on test zone, dosage is
2mg/cm2.3. carrying out final test using rear 120min, 5 points of every piece of domain test are averaged.Moistening effect is evaluated
Judgement schematics:In opposite moisturizing rate/%=(P sample t=x-P blank)/(P marks t=x-P blank) X100% formulas:P samples t=x-
Use the conductivity of product after a certain period of time;P blank-is not coated with the conductivity of sample;P marks t=x- and uses reference after a certain period of time
The conductivity of object, the results are shown in table below for the moisturizing rate situation (%) that cosmetics of the invention and glycerine compare:
In terms of above table, the moisturizing rate of cosmetics of the invention is apparently higher than the moisturizing situation of glycerine, while also illustrating
The polypeptide of the present invention has significant facilitation for the moistening effect for improving cosmetics.
6 senile-resistant efficacy evaluation test of embodiment
Cosmetics detect the anti-aging effects of skin
Free radical is the intermediate product of biochemical reaction during vital movement, and biology related with life aging is freely
Base is mainly some oxygen containing free radicals, and antioxidant can provide proton to peroxide radical, it is thus possible to inhibit lipid
Autoxidizable chain reaction.Usually make DPPH to examine antioxidant to put forward protogenic ability.DPPH is a kind of very stable
Free radical, methanol solution has an extremely strong absorbance at 517nm, but when by oxidant (AH) or free radical (when RO is restored,
Its absorbance can be reduced or be disappeared.It can judge whether sample has removing freely using absorbance of the sample at 517nm as a result,
The ability of base.
Take cosmetics, the solution of 100mg cosmetics/ml be configured to PBS, respectively with 3.8ml methanol solutions, Iml
(DPPH) radical methanol solutions (2Xl0-4mol/L), is fully mixed evenly, and after standing 30min, is measured with spectrophotometric
Absorbance at 517nm, and its free radical scavenging activity is calculated with formula.Free radical scavenging activity (%)=[(Ac-As/Ac)] X100%
As:Absorbance of the sample containing determinand at 517nm;Ac:Absorbance of the sample without determinand at 517nm is different
The free radical scavenging activity (%) of the Chinese medical extract of volume, result are following (the unit % of result):
As can be seen from the table, cosmetics of the invention are higher for free radical scavenging activity.Illustrate the cosmetics of the present invention
With good anti-aging ability.
7 face cream whitening effect of embodiment detects
Each 61 of the deeper men and women volunteer of the colour of skin is selected, to the cosmetics of the right face present invention, progress after morning and evening face cleaning
Sooner or later it is spaced the smearing of 12h, left face as a contrast, only smears the cosmetics of embodiment 4, tries out surrounding, filled out according to sensory evaluation
Write evaluation table on probation.Best result 4 divides for significant effect, minimum to be divided into 1, contrast effect unobvious.Respectively card is utilized in 4th week
Fang Jinhang is counted.
By detect find, containing HFP-1~60 polypeptide cosmetics after having used four weeks, right face occurs significantly
Spot fading effect (P<0.05).Data above illustrates that the present invention has the effect of whitening.And right face uses the left and right face of glycerine
Portion is not significantly different, and illustrates that the cosmetics of the present invention have more significant white-skinned face function.
Sequence table
<110>Gu Yinfeng
<120>A kind of cosmetics with anti-aging, whitening, moisture-keeping efficacy
<160> 60
<170> SIPOSequenceListing 1.0
<210> 1
<211> 19
<212> PRT
<213>Artificial sequence (2 Ambystoma laterale x Ambystoma jeffersonianum)
<400> 1
Arg Phe Ile Val His Ser Leu Pro Lys Pro Ser Met His Pro Ala Gln
1 5 10 15
Arg Arg Arg
<210> 2
<211> 19
<212> PRT
<213>Artificial sequence (2 Ambystoma laterale x Ambystoma jeffersonianum)
<400> 2
Pro Gln Gln Cys Val Leu Val Gln Thr Thr Trp Met Ser Leu Glu Gly
1 5 10 15
Gly Arg Ser
<210> 3
<211> 18
<212> PRT
<213>Artificial sequence (2 Ambystoma laterale x Ambystoma jeffersonianum)
<400> 3
Pro Pro Arg Pro Tyr Tyr Pro Gln Gln Thr Glu Phe Ser His Asp Gln
1 5 10 15
Arg Lys
<210> 4
<211> 18
<212> PRT
<213>Artificial sequence (2 Ambystoma laterale x Ambystoma jeffersonianum)
<400> 4
Arg Leu Leu Ser Ser Asp Trp Asn Gln Leu Gln Glu Tyr Trp Arg Tyr
1 5 10 15
Met Val
<210> 5
<211> 17
<212> PRT
<213>Artificial sequence (2 Ambystoma laterale x Ambystoma jeffersonianum)
<400> 5
Trp Arg His Arg Asn Trp Gln Gly Gln Gly Leu Gly Arg Gly Asp Asp
1 5 10 15
Asp
<210> 6
<211> 16
<212> PRT
<213>Artificial sequence (2 Ambystoma laterale x Ambystoma jeffersonianum)
<400> 6
Asp Arg Asp Met Leu Ile Ala Gln Thr Met Lys Gly Thr Val Thr Ser
1 5 10 15
<210> 7
<211> 17
<212> PRT
<213>Artificial sequence (2 Ambystoma laterale x Ambystoma jeffersonianum)
<400> 7
Gly Ile Phe Phe Thr Glu Thr Leu Asn Ser Asn Cys Thr Glu Thr Tyr
1 5 10 15
Pro
<210> 8
<211> 16
<212> PRT
<213>Artificial sequence (2 Ambystoma laterale x Ambystoma jeffersonianum)
<400> 8
Leu Trp Ala Lys Trp Trp His Leu Ile Tyr Pro His His Tyr Ile His
1 5 10 15
<210> 9
<211> 19
<212> PRT
<213>Artificial sequence (2 Ambystoma laterale x Ambystoma jeffersonianum)
<400> 9
Met Lys His Trp Leu Arg Asn Glu Trp Arg Ile Glu Arg Val Met Asp
1 5 10 15
Gln Gln Ala
<210> 10
<211> 18
<212> PRT
<213>Artificial sequence (2 Ambystoma laterale x Ambystoma jeffersonianum)
<400> 10
Pro Asp Leu Met Tyr Ser Tyr Pro Pro Thr Ile Gln Ile Ile Gly Leu
1 5 10 15
Asn Thr
<210> 11
<211> 17
<212> PRT
<213>Artificial sequence (2 Ambystoma laterale x Ambystoma jeffersonianum)
<400> 11
Ala Met Gly Lys Met Thr Asn Phe Val Leu Ser His Asn Pro Thr Ser
1 5 10 15
Thr
<210> 12
<211> 16
<212> PRT
<213>Artificial sequence (2 Ambystoma laterale x Ambystoma jeffersonianum)
<400> 12
Thr Ile Thr Tyr Ser Thr Gln Leu Ile Arg Arg Tyr Arg Ser His Met
1 5 10 15
<210> 13
<211> 19
<212> PRT
<213>Artificial sequence (2 Ambystoma laterale x Ambystoma jeffersonianum)
<400> 13
Asp Ser Cys Val Gln Ala Ile His Trp Met Trp Trp Asp Glu Val Leu
1 5 10 15
Ser Gly Tyr
<210> 14
<211> 18
<212> PRT
<213>Artificial sequence (2 Ambystoma laterale x Ambystoma jeffersonianum)
<400> 14
Ile Asn Lys Pro Trp Gln Gln Ser Gly His Phe Ala Asp Ser Trp Lys
1 5 10 15
Arg Gly
<210> 15
<211> 17
<212> PRT
<213>Artificial sequence (2 Ambystoma laterale x Ambystoma jeffersonianum)
<400> 15
Val Met Phe Thr Asp Ile Lys Cys Pro Cys Gln Phe Ala His Met Asn
1 5 10 15
Asp
<210> 16
<211> 16
<212> PRT
<213>Artificial sequence (2 Ambystoma laterale x Ambystoma jeffersonianum)
<400> 16
Leu Pro Ile Pro Arg Lys Thr Ser Pro Trp Cys Ile Trp Ser Tyr Asn
1 5 10 15
<210> 17
<211> 19
<212> PRT
<213>Artificial sequence (2 Ambystoma laterale x Ambystoma jeffersonianum)
<400> 17
Arg Val Ser Met Tyr Trp Glu Arg Ser Asp Asn Gly Phe His Gln Arg
1 5 10 15
Gln Glu Ser
<210> 18
<211> 18
<212> PRT
<213>Artificial sequence (2 Ambystoma laterale x Ambystoma jeffersonianum)
<400> 18
Leu Pro Gly Asp Thr His Ala Pro Trp Trp Trp Arg Pro Val Leu Ile
1 5 10 15
Ala Lys
<210> 19
<211> 17
<212> PRT
<213>Artificial sequence (2 Ambystoma laterale x Ambystoma jeffersonianum)
<400> 19
Ala Met His Gly Met Phe Ser Thr Glu Gly Thr Pro Gln Glu Asp Ala
1 5 10 15
Pro
<210> 20
<211> 16
<212> PRT
<213>Artificial sequence (2 Ambystoma laterale x Ambystoma jeffersonianum)
<400> 20
Arg Ser His Trp His Glu Ala Trp His Leu Val Cys Ile Gly Gly His
1 5 10 15
<210> 21
<211> 19
<212> PRT
<213>Artificial sequence (2 Ambystoma laterale x Ambystoma jeffersonianum)
<400> 21
Ile Pro His Gln Glu Leu Trp Gln Lys Tyr Ser Gln Ile Phe Leu Pro
1 5 10 15
Trp Thr Ser
<210> 22
<211> 19
<212> PRT
<213>Artificial sequence (2 Ambystoma laterale x Ambystoma jeffersonianum)
<400> 22
Arg Leu Glu Ser Lys Arg Ile Pro Phe Gln Arg Gly Glu Pro Arg Gly
1 5 10 15
Pro Met Tyr
<210> 23
<211> 18
<212> PRT
<213>Artificial sequence (2 Ambystoma laterale x Ambystoma jeffersonianum)
<400> 23
Glu Trp Cys His Gln Cys Trp Met Cys Gly Val Ala Gln Met Trp Gly
1 5 10 15
His Phe
<210> 24
<211> 17
<212> PRT
<213>Artificial sequence (2 Ambystoma laterale x Ambystoma jeffersonianum)
<400> 24
Pro Tyr Met Ala Gly Pro Pro Arg Asp Arg Glu Gly Ile His Phe Leu
1 5 10 15
His
<210> 25
<211> 16
<212> PRT
<213>Artificial sequence (2 Ambystoma laterale x Ambystoma jeffersonianum)
<400> 25
Glu Tyr Glu Gly Gly Trp Pro Asn Glu Gln Ala Pro Ala Pro Lys Gly
1 5 10 15
<210> 26
<211> 18
<212> PRT
<213>Artificial sequence (2 Ambystoma laterale x Ambystoma jeffersonianum)
<400> 26
Asn Pro Pro His Arg Cys Ala Asp His Gln Gln Glu Val Met Val Ser
1 5 10 15
Phe His
<210> 27
<211> 17
<212> PRT
<213>Artificial sequence (2 Ambystoma laterale x Ambystoma jeffersonianum)
<400> 27
Lys Lys Phe Phe Thr Glu Trp Gly Val Gly Ser Gln Gln Gly Ala Pro
1 5 10 15
Asn
<210> 28
<211> 16
<212> PRT
<213>Artificial sequence (2 Ambystoma laterale x Ambystoma jeffersonianum)
<400> 28
Leu Phe Ile His Cys Arg Val Lys Lys Arg Met Thr Cys His Glu Trp
1 5 10 15
<210> 29
<211> 19
<212> PRT
<213>Artificial sequence (2 Ambystoma laterale x Ambystoma jeffersonianum)
<400> 29
Glu Met Ile Trp Lys Gly Arg Arg Thr Pro Val Thr Asp Ile Ala Arg
1 5 10 15
Pro Leu Val
<210> 30
<211> 18
<212> PRT
<213>Artificial sequence (2 Ambystoma laterale x Ambystoma jeffersonianum)
<400> 30
Asn Pro Trp Arg Cys Arg Val Met Arg Pro Glu Arg Cys His Asp Ile
1 5 10 15
Asn Gln
<210> 31
<211> 17
<212> PRT
<213>Artificial sequence (2 Ambystoma laterale x Ambystoma jeffersonianum)
<400> 31
Ile Trp His Met Cys Thr Lys Thr Trp Arg Phe Ile Asp Ser Phe Glu
1 5 10 15
Lys
<210> 32
<211> 16
<212> PRT
<213>Artificial sequence (2 Ambystoma laterale x Ambystoma jeffersonianum)
<400> 32
Trp Val Ser Arg Trp Val Met Phe Ser Pro His Pro Leu Pro Val Met
1 5 10 15
<210> 33
<211> 19
<212> PRT
<213>Artificial sequence (2 Ambystoma laterale x Ambystoma jeffersonianum)
<400> 33
Met Gly Ile Arg Ser Trp Trp Cys Ile Leu Met Ile Trp Gln His Pro
1 5 10 15
Arg Gln Tyr
<210> 34
<211> 18
<212> PRT
<213>Artificial sequence (2 Ambystoma laterale x Ambystoma jeffersonianum)
<400> 34
Ile Ile Thr Gln Tyr Val Tyr Pro Asp Leu Trp Tyr Val Gln Pro Trp
1 5 10 15
Gly Ile
<210> 35
<211> 17
<212> PRT
<213>Artificial sequence (2 Ambystoma laterale x Ambystoma jeffersonianum)
<400> 35
Leu Ser Asp Phe Thr Trp Met Asn Leu Arg Glu Gly Trp Gly Gly Val
1 5 10 15
Glu
<210> 36
<211> 16
<212> PRT
<213>Artificial sequence (2 Ambystoma laterale x Ambystoma jeffersonianum)
<400> 36
Val Tyr Ser His Arg Tyr Cys Leu Thr Trp Glu His Asn Leu His Ala
1 5 10 15
<210> 37
<211> 18
<212> PRT
<213>Artificial sequence (2 Ambystoma laterale x Ambystoma jeffersonianum)
<400> 37
Gly Tyr His Ser His Gly Leu Trp His Phe Arg Trp His Leu Ile Tyr
1 5 10 15
Met Arg
<210> 38
<211> 17
<212> PRT
<213>Artificial sequence (2 Ambystoma laterale x Ambystoma jeffersonianum)
<400> 38
Val Phe Arg Asn Thr Trp Trp Val Glu His Tyr Asp Gly Thr Ser Asn
1 5 10 15
Arg
<210> 39
<211> 16
<212> PRT
<213>Artificial sequence (2 Ambystoma laterale x Ambystoma jeffersonianum)
<400> 39
Leu Gln Leu Pro Arg Val Pro Thr His Met Tyr Pro Ser His Leu Asn
1 5 10 15
<210> 40
<211> 19
<212> PRT
<213>Artificial sequence (2 Ambystoma laterale x Ambystoma jeffersonianum)
<400> 40
Val Tyr Asp Leu Trp Thr Asp Gln Gln Ser Trp Asp Phe Gly Arg His
1 5 10 15
Ile Pro Pro
<210> 41
<211> 19
<212> PRT
<213>Artificial sequence (2 Ambystoma laterale x Ambystoma jeffersonianum)
<400> 41
Gln Tyr Arg Asn Pro Glu Phe Gln His Asn Ser Trp Thr Ser Asp Ile
1 5 10 15
Lys Asn Ile
<210> 42
<211> 19
<212> PRT
<213>Artificial sequence (2 Ambystoma laterale x Ambystoma jeffersonianum)
<400> 42
Trp Asp His Ala Arg Arg Trp His His Asp Tyr Glu Trp Pro Arg Ser
1 5 10 15
Cys Arg Arg
<210> 43
<211> 19
<212> PRT
<213>Artificial sequence (2 Ambystoma laterale x Ambystoma jeffersonianum)
<400> 43
Lys Met Glu Met His Asp Asp Tyr Ser Tyr Lys Phe Ile Cys Ser Gln
1 5 10 15
Gln Trp Gly
<210> 44
<211> 18
<212> PRT
<213>Artificial sequence (2 Ambystoma laterale x Ambystoma jeffersonianum)
<400> 44
Gly Ser Trp Leu Asn Asn Pro Arg Asn Ser Val Gly Asp Pro Glu Cys
1 5 10 15
Phe Gly
<210> 45
<211> 19
<212> PRT
<213>Artificial sequence (2 Ambystoma laterale x Ambystoma jeffersonianum)
<400> 45
Phe Lys Gly Gly His Pro Asp Gln Val Asp Phe Lys Arg Leu Arg Tyr
1 5 10 15
Gln His Pro
<210> 46
<211> 19
<212> PRT
<213>Artificial sequence (2 Ambystoma laterale x Ambystoma jeffersonianum)
<400> 46
Pro His Asn Met Met Leu Val His Leu Val Leu His Ser Gly Asn Gln
1 5 10 15
Tyr Gly His
<210> 47
<211> 18
<212> PRT
<213>Artificial sequence (2 Ambystoma laterale x Ambystoma jeffersonianum)
<400> 47
Phe Cys Ser Trp Gln Phe Pro Asp Glu Leu Cys Tyr Thr Ser Ile Ser
1 5 10 15
Ser Tyr
<210> 48
<211> 17
<212> PRT
<213>Artificial sequence (2 Ambystoma laterale x Ambystoma jeffersonianum)
<400> 48
Ile Gly Glu Thr Arg Cys Gln Gln Asn Gln Phe Lys Leu Leu Arg Gly
1 5 10 15
Gly
<210> 49
<211> 16
<212> PRT
<213>Artificial sequence (2 Ambystoma laterale x Ambystoma jeffersonianum)
<400> 49
Pro Lys Pro Gly Ala Asn Ile Ile Tyr Glu Arg Glu Cys Pro Pro Tyr
1 5 10 15
<210> 50
<211> 18
<212> PRT
<213>Artificial sequence (2 Ambystoma laterale x Ambystoma jeffersonianum)
<400> 50
Asp Gln Trp Ser Trp Pro Gln Glu His Lys Leu Pro Ser Arg Gly Ser
1 5 10 15
Gln Gln
<210> 51
<211> 17
<212> PRT
<213>Artificial sequence (2 Ambystoma laterale x Ambystoma jeffersonianum)
<400> 51
Asn Cys Glu Gly Thr Lys Arg Ile Ser Glu Leu Ile Cys Ile Ile Lys
1 5 10 15
His
<210> 52
<211> 16
<212> PRT
<213>Artificial sequence (2 Ambystoma laterale x Ambystoma jeffersonianum)
<400> 52
Asn Thr Cys Trp Ser Arg Asp His Met Ile Cys Phe Trp His Val Cys
1 5 10 15
<210> 53
<211> 17
<212> PRT
<213>Artificial sequence (2 Ambystoma laterale x Ambystoma jeffersonianum)
<400> 53
Ser Ser Ile Asn Gln His Gln Tyr Gly Asn Arg Ala Glu Ser His Leu
1 5 10 15
Met
<210> 54
<211> 16
<212> PRT
<213>Artificial sequence (2 Ambystoma laterale x Ambystoma jeffersonianum)
<400> 54
Ile Trp Trp Val Leu Phe Phe Pro Gln Ile Tyr Trp Thr Gly Pro His
1 5 10 15
<210> 55
<211> 18
<212> PRT
<213>Artificial sequence (2 Ambystoma laterale x Ambystoma jeffersonianum)
<400> 55
Glu Tyr Lys Ser Ser Leu His Leu Gly Arg Trp Ser Trp Trp Ser Met
1 5 10 15
Asn Gly
<210> 56
<211> 17
<212> PRT
<213>Artificial sequence (2 Ambystoma laterale x Ambystoma jeffersonianum)
<400> 56
Thr Asp Pro Phe Asn Phe Asn Ser Met Thr Tyr His Arg Arg His Cys
1 5 10 15
Val
<210> 57
<211> 16
<212> PRT
<213>Artificial sequence (2 Ambystoma laterale x Ambystoma jeffersonianum)
<400> 57
Cys His Thr Tyr Pro Ser Pro Leu Asn Ala Tyr His Trp Phe Lys Ser
1 5 10 15
<210> 58
<211> 18
<212> PRT
<213>Artificial sequence (2 Ambystoma laterale x Ambystoma jeffersonianum)
<400> 58
Asp Lys Gln Gly Gln Ile Leu Thr Glu Thr Lys Lys Ser Ser Gln Glu
1 5 10 15
Gln Cys
<210> 59
<211> 17
<212> PRT
<213>Artificial sequence (2 Ambystoma laterale x Ambystoma jeffersonianum)
<400> 59
Trp Gly Ser Val Thr Ser Arg Met Gly His Val Ala Asp Pro Gln Leu
1 5 10 15
His
<210> 60
<211> 16
<212> PRT
<213>Artificial sequence (2 Ambystoma laterale x Ambystoma jeffersonianum)
<400> 60
Asn His Cys Met His Phe His Asn Cys Tyr His Pro Cys Arg Cys Trp
1 5 10 15
Claims (3)
1. a kind of cosmetics, which is characterized in that include each component of following parts by weight:2 parts of olive oil, 0.5 part of D-pantothenyl aleohol, dimension life
0.5 part of plain E, 0.1 part of glutathione, 1 part of pyrrolidone sodium carboxylate, 2 parts of glycerine, 1 part of sodium lactate, 0.1 part of essence, 5 parts of purifying
Water, 0.1 part of pomegranate polypeptide.
2. cosmetics as described in claim 1, which is characterized in that the pomegranate polypeptide sequence such as SEQ ID NO:17-60
Shown in any.
3. a kind of polypeptide, sequence such as SEQ ID NO:Shown in 17-60 is any.
Priority Applications (1)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
CN201810543087.5A CN108578277A (en) | 2016-02-13 | 2016-02-13 | A kind of cosmetics with anti-aging, whitening, moisture-keeping efficacy |
Applications Claiming Priority (2)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
CN201810543087.5A CN108578277A (en) | 2016-02-13 | 2016-02-13 | A kind of cosmetics with anti-aging, whitening, moisture-keeping efficacy |
CN201610083775.9A CN105596229B (en) | 2016-02-13 | 2016-02-13 | A kind of cosmetics with anti-aging, whitening, moisture-keeping efficacy |
Related Parent Applications (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
CN201610083775.9A Division CN105596229B (en) | 2016-02-13 | 2016-02-13 | A kind of cosmetics with anti-aging, whitening, moisture-keeping efficacy |
Publications (1)
Publication Number | Publication Date |
---|---|
CN108578277A true CN108578277A (en) | 2018-09-28 |
Family
ID=55976969
Family Applications (17)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
CN201710226368.3A Pending CN106880527A (en) | 2016-02-13 | 2016-02-13 | A kind of cosmetics with anti-aging, whitening, moisture-keeping efficacy |
CN201710226366.4A Pending CN106880526A (en) | 2016-02-13 | 2016-02-13 | A kind of cosmetics with anti-aging, whitening, moisture-keeping efficacy |
CN201710226367.9A Pending CN106821804A (en) | 2016-02-13 | 2016-02-13 | A kind of cosmetics with anti-aging, whitening, moisture-keeping efficacy |
CN201710226376.8A Withdrawn CN106726680A (en) | 2016-02-13 | 2016-02-13 | A kind of cosmetics with anti-aging, whitening, moisture-keeping efficacy |
CN201810543087.5A Pending CN108578277A (en) | 2016-02-13 | 2016-02-13 | A kind of cosmetics with anti-aging, whitening, moisture-keeping efficacy |
CN201610083775.9A Active CN105596229B (en) | 2016-02-13 | 2016-02-13 | A kind of cosmetics with anti-aging, whitening, moisture-keeping efficacy |
CN201710226358.XA Pending CN106726675A (en) | 2016-02-13 | 2016-02-13 | A kind of cosmetics with anti-aging, whitening, moisture-keeping efficacy |
CN201710226377.2A Withdrawn CN106821787A (en) | 2016-02-13 | 2016-02-13 | A kind of cosmetics with anti-aging, whitening, moisture-keeping efficacy |
CN201710226363.0A Withdrawn CN106821786A (en) | 2016-02-13 | 2016-02-13 | A kind of cosmetics with anti-aging, whitening, moisture-keeping efficacy |
CN201710226365.XA Withdrawn CN106726677A (en) | 2016-02-13 | 2016-02-13 | A kind of cosmetics with anti-aging, whitening, moisture-keeping efficacy |
CN201710226360.7A Pending CN106726676A (en) | 2016-02-13 | 2016-02-13 | A kind of cosmetics with anti-aging, whitening, moisture-keeping efficacy |
CN201710226371.5A Pending CN106726679A (en) | 2016-02-13 | 2016-02-13 | A kind of cosmetics with anti-aging, whitening, moisture-keeping efficacy |
CN201710226872.3A Withdrawn CN106880528A (en) | 2016-02-13 | 2016-02-13 | A kind of cosmetics with anti-aging, whitening, moisture-keeping efficacy |
CN201710226362.6A Pending CN106806162A (en) | 2016-02-13 | 2016-02-13 | A kind of cosmetics with anti-aging, whitening, moisture-keeping efficacy |
CN201710226369.8A Pending CN106726678A (en) | 2016-02-13 | 2016-02-13 | A kind of cosmetics with anti-aging, whitening, moisture-keeping efficacy |
CN201710226364.5A Withdrawn CN106880525A (en) | 2016-02-13 | 2016-02-13 | A kind of cosmetics with anti-aging, whitening, moisture-keeping efficacy |
CN201710226372.XA Pending CN106806163A (en) | 2016-02-13 | 2016-02-13 | A kind of cosmetics with anti-aging, whitening, moisture-keeping efficacy |
Family Applications Before (4)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
CN201710226368.3A Pending CN106880527A (en) | 2016-02-13 | 2016-02-13 | A kind of cosmetics with anti-aging, whitening, moisture-keeping efficacy |
CN201710226366.4A Pending CN106880526A (en) | 2016-02-13 | 2016-02-13 | A kind of cosmetics with anti-aging, whitening, moisture-keeping efficacy |
CN201710226367.9A Pending CN106821804A (en) | 2016-02-13 | 2016-02-13 | A kind of cosmetics with anti-aging, whitening, moisture-keeping efficacy |
CN201710226376.8A Withdrawn CN106726680A (en) | 2016-02-13 | 2016-02-13 | A kind of cosmetics with anti-aging, whitening, moisture-keeping efficacy |
Family Applications After (12)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
CN201610083775.9A Active CN105596229B (en) | 2016-02-13 | 2016-02-13 | A kind of cosmetics with anti-aging, whitening, moisture-keeping efficacy |
CN201710226358.XA Pending CN106726675A (en) | 2016-02-13 | 2016-02-13 | A kind of cosmetics with anti-aging, whitening, moisture-keeping efficacy |
CN201710226377.2A Withdrawn CN106821787A (en) | 2016-02-13 | 2016-02-13 | A kind of cosmetics with anti-aging, whitening, moisture-keeping efficacy |
CN201710226363.0A Withdrawn CN106821786A (en) | 2016-02-13 | 2016-02-13 | A kind of cosmetics with anti-aging, whitening, moisture-keeping efficacy |
CN201710226365.XA Withdrawn CN106726677A (en) | 2016-02-13 | 2016-02-13 | A kind of cosmetics with anti-aging, whitening, moisture-keeping efficacy |
CN201710226360.7A Pending CN106726676A (en) | 2016-02-13 | 2016-02-13 | A kind of cosmetics with anti-aging, whitening, moisture-keeping efficacy |
CN201710226371.5A Pending CN106726679A (en) | 2016-02-13 | 2016-02-13 | A kind of cosmetics with anti-aging, whitening, moisture-keeping efficacy |
CN201710226872.3A Withdrawn CN106880528A (en) | 2016-02-13 | 2016-02-13 | A kind of cosmetics with anti-aging, whitening, moisture-keeping efficacy |
CN201710226362.6A Pending CN106806162A (en) | 2016-02-13 | 2016-02-13 | A kind of cosmetics with anti-aging, whitening, moisture-keeping efficacy |
CN201710226369.8A Pending CN106726678A (en) | 2016-02-13 | 2016-02-13 | A kind of cosmetics with anti-aging, whitening, moisture-keeping efficacy |
CN201710226364.5A Withdrawn CN106880525A (en) | 2016-02-13 | 2016-02-13 | A kind of cosmetics with anti-aging, whitening, moisture-keeping efficacy |
CN201710226372.XA Pending CN106806163A (en) | 2016-02-13 | 2016-02-13 | A kind of cosmetics with anti-aging, whitening, moisture-keeping efficacy |
Country Status (1)
Country | Link |
---|---|
CN (17) | CN106880527A (en) |
Families Citing this family (2)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
CN106137785B (en) * | 2016-08-03 | 2019-05-17 | 夏献民 | A kind of regenerated skin care item of promotion skin repair |
CN112294720A (en) * | 2020-11-12 | 2021-02-02 | 珂蓝(重庆)化妆品有限公司 | Composition for protecting skin from pigment and application thereof |
Family Cites Families (4)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
US9084734B2 (en) * | 2005-05-05 | 2015-07-21 | Danisco Us Inc. | Peptide personal care compositions and methods for their use |
ATE544441T1 (en) * | 2007-05-10 | 2012-02-15 | Neubourg Skin Care Gmbh & Co Kg | SURFACTANT-FREE FOAM FORMULATIONS |
CN103251524B (en) * | 2013-05-06 | 2015-02-11 | 广州立白企业集团有限公司 | Foam facial mask composition and preparation method thereof |
CN103860453B (en) * | 2014-04-11 | 2016-03-09 | 六安市丹皇生物科技有限责任公司 | A kind of face of living is compacted emollient cream and preparation method thereof |
-
2016
- 2016-02-13 CN CN201710226368.3A patent/CN106880527A/en active Pending
- 2016-02-13 CN CN201710226366.4A patent/CN106880526A/en active Pending
- 2016-02-13 CN CN201710226367.9A patent/CN106821804A/en active Pending
- 2016-02-13 CN CN201710226376.8A patent/CN106726680A/en not_active Withdrawn
- 2016-02-13 CN CN201810543087.5A patent/CN108578277A/en active Pending
- 2016-02-13 CN CN201610083775.9A patent/CN105596229B/en active Active
- 2016-02-13 CN CN201710226358.XA patent/CN106726675A/en active Pending
- 2016-02-13 CN CN201710226377.2A patent/CN106821787A/en not_active Withdrawn
- 2016-02-13 CN CN201710226363.0A patent/CN106821786A/en not_active Withdrawn
- 2016-02-13 CN CN201710226365.XA patent/CN106726677A/en not_active Withdrawn
- 2016-02-13 CN CN201710226360.7A patent/CN106726676A/en active Pending
- 2016-02-13 CN CN201710226371.5A patent/CN106726679A/en active Pending
- 2016-02-13 CN CN201710226872.3A patent/CN106880528A/en not_active Withdrawn
- 2016-02-13 CN CN201710226362.6A patent/CN106806162A/en active Pending
- 2016-02-13 CN CN201710226369.8A patent/CN106726678A/en active Pending
- 2016-02-13 CN CN201710226364.5A patent/CN106880525A/en not_active Withdrawn
- 2016-02-13 CN CN201710226372.XA patent/CN106806163A/en active Pending
Also Published As
Publication number | Publication date |
---|---|
CN106726676A (en) | 2017-05-31 |
CN106880528A (en) | 2017-06-23 |
CN105596229A (en) | 2016-05-25 |
CN106806163A (en) | 2017-06-09 |
CN106726677A (en) | 2017-05-31 |
CN106880526A (en) | 2017-06-23 |
CN106821786A (en) | 2017-06-13 |
CN106806162A (en) | 2017-06-09 |
CN106880525A (en) | 2017-06-23 |
CN106726678A (en) | 2017-05-31 |
CN106726675A (en) | 2017-05-31 |
CN105596229B (en) | 2017-05-31 |
CN106880527A (en) | 2017-06-23 |
CN106821787A (en) | 2017-06-13 |
CN106726679A (en) | 2017-05-31 |
CN106726680A (en) | 2017-05-31 |
CN106821804A (en) | 2017-06-13 |
Similar Documents
Publication | Publication Date | Title |
---|---|---|
CN108852894A (en) | It is a kind of for repairing the polypeptides in combination of whitening wrinkle-removing | |
KR101796694B1 (en) | Cosmetic composition for improving skin whitening and lifting | |
US20080160114A1 (en) | Composition of Skin External Application Containing Rose Extract and Epigallocatechin Gallate(Egcg) | |
CN107714559A (en) | One kind is without anti-corrosion deep water supplement skin care item | |
CN109303727A (en) | A kind of compound anti-apolexis composition and its application containing plant extracts | |
CN106333894A (en) | Method for preparing natural sunscreen and skin whitening components in cosmetics by utilizing fruits | |
CN112545955B (en) | Anti-aging repair composition and preparation method and application thereof | |
CN109350579B (en) | Whitening cosmetic additive, whitening skin-refreshing lotion and preparation method thereof | |
CN109330954B (en) | Whitening skin brightening lotion, preparation method thereof and tyrosinase inhibitor | |
CN110063911A (en) | A kind of compound small active peptides Essence | |
CN107510617A (en) | Phycocyanin protective agent and preparation method thereof and phycocyanin composition and moisturizing astringent | |
JP2000136124A (en) | Skin lotion | |
CN108578277A (en) | A kind of cosmetics with anti-aging, whitening, moisture-keeping efficacy | |
CN112220693A (en) | Solid spray containing Norwegian spruce leaf extract for after-sun repair and preparation method thereof | |
CN112675060A (en) | Composition and skin care product for resisting skin aging and preparation method thereof | |
CN111603404A (en) | Skin care essence containing cell extracting solution and preparation method thereof | |
CN113876671A (en) | Anti-aging composition containing rape bud extract and preparation method thereof | |
CN112535657A (en) | Light protection repair composition, preparation method and application thereof, and skin care product | |
CN105662925B (en) | A kind of cosmetics with spot-removing function | |
CN110292538B (en) | Composition and application thereof in preparation of whitening and anti-aging cosmetics | |
KR20060031329A (en) | A COMPOSITION CONTAINING beta-1,3-GLUCANE AND DEEP SEA WATER FOR ENHANCING SKIN ELASTICITY | |
EP3760185A1 (en) | Cosmetic composition to prevent and delay skin aging | |
CN113101252A (en) | Collagenase inhibitor, moisturizing lotion containing collagenase inhibitor and preparation method of moisturizing lotion | |
CN116807954A (en) | Scalp hair skin repairing composition using mother-of-pearl extract as raw material and preparation method and application thereof | |
CN113041182A (en) | Collagenase inhibitor, anti-aging skin lightening lotion containing collagenase inhibitor and preparation method |
Legal Events
Date | Code | Title | Description |
---|---|---|---|
PB01 | Publication | ||
PB01 | Publication | ||
WD01 | Invention patent application deemed withdrawn after publication | ||
WD01 | Invention patent application deemed withdrawn after publication |
Application publication date: 20180928 |